LB PHARMACEUTICALS INC

LBRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.9B · 27 employees
21
SEC Filings
$39.42
Close 2026-10-22
27
Employees

Business Summary

LB Pharmaceuticals Inc. is a late-stage biopharmaceutical company developing novel therapies for neuropsychiatric disorders including schizophrenia, bipolar depression, and major depressive disorder. Its lead product candidate, LB-102, is a new chemical entity and methylated derivative of amisulpride, a second-generation antipsychotic approved in over 50 countries. LB-102 is in late-stage clinical development for schizophrenia and bipolar depression, with a Phase 3 trial initiated in March 2026.

Latest Stock Quote

LBRX 2026-10-22 $39.42 O:$39.12 H:$41.58 L:$38.3912 Vol:0.2M VWAP:$39.3641
origin leaf: null

Next Earnings

expected 2026-12-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126368EDGAR118K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-052026-09-300001193125-26-449994EDGAR75K words
2026-08-112026-06-300001193125-26-343490EDGAR74K words
2025-11-062025-09-300001193125-25-268174EDGAR73K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-050001193125-26-449887EDGAR3K words
2026-09-150001193125-26-391358EDGAR1K words
2026-09-030001193125-26-381076EDGAR1K words
2026-08-110001193125-26-343479EDGAR3K words
2026-07-290001193125-26-322208EDGAR1K words
2026-07-220001193125-26-311357EDGAR1K words
2026-03-260001193125-26-126223EDGAR3K words
2026-03-160001193125-26-108474EDGAR1K words
2026-03-100001193125-26-099419EDGAR1K words
2026-02-050001193125-26-038539EDGAR1K words

21 total filings indexed. 7 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

schizophrenia bipolar-depression major-depressive-disorder-(mdd) neuropsychiatric-disorders branded-antipsychotic-drug-market-(u.s.,-~$12-billion-as-of-2024)

Company Identity

CIK0001691082
TickerLBRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.lbpharma.us
Listed2025-09-11

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: c0b07cb9e9c3b501d164b47edf8980099c766b239a2e23db02538d5c0973b4ca
parent: 6f9f4a9cc0cfceb8867310a7df5f6ea9b8b0fc89be2d5f933ed3eee9fb2e1bca
content hash: 7ad83025dbaec73286750c504ebebd9b3d1417060e654f2fed98aa0888d9da25
signed: 2026-11-16T19:03:13.785Z
sources: 4 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up LBRX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on LBRX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/LBRX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.